Stereotactic Body Radiation Therapy trials for Prostate cancer

All Stereotactic Body Radiation Therapy trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Stereotactic Body Radiation Therapy for Prostate cancer

• Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
  NCT05915442 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: Male · 1 location
• Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
  NCT07548164 · Phase: Phase 3 · Ages: No age limits stated · Sex: Male · 8 locations
• Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
  NCT04693377 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
  NCT05616650 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: Male · 1 location
• High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
  NCT04945642 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.
  NCT06369246 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
  NCT06205316 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 6 locations
• Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
  NCT06378866 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
  NCT03392233 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
  NCT05946213 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 413 locations
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
  NCT04423211 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 341 locations
• Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
  NCT06276465 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 4 locations

Common questions

How many trials study Stereotactic Body Radiation Therapy for Prostate cancer?

12 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.